- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: cell-mediated immune response
Total 68336 results
-
University Hospital, BonnRecruitingFollicular Lymphoma | Multiple Myeloma | Myocarditis | Cytokine Release Syndrome | DLBCL | MCL | ALL | CAR T-cell Therapy | PCBCLGermany
-
National Research Centre, EgyptTheodor Bilharz Research Institute; The holding company for biological products...RecruitingImmune Response to Covid 19 VaccinationEgypt
-
Catharina Ziekenhuis EindhovenZonMw: The Netherlands Organisation for Health Research and Development; Stichting... and other collaboratorsRecruitingCervical Intraepithelial Neoplasia | CIN 2/3 | Cervical Intraepithelial Neoplasia Grade 2/3 | Cervical High Grade Squamous Intraepithelial LesionNetherlands
-
Abu Dhabi Health Services CompanyRecruiting
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyRecruitingMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, Canada, Spain
-
Abramson Cancer Center at Penn MedicineRecruitingBreast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | ER Positive Breast CancerUnited States
-
University of California, San FranciscoSun Pharmaceutical Industries LimitedRecruiting
-
University of SulaimaniRecruitingRheumatoid Arthritis | Inflammatory Arthritis | Ankylosing SpondylitisIraq
-
Aditxt, Inc.Recruiting
-
MRC/UVRI and LSHTM Uganda Research UnitInternational AIDS Vaccine InitiativeRecruitingAcute Human Immunodeficiency Virus Type I InfectionUganda
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingLymphoma | Metastatic Malignant Solid NeoplasmUnited States
-
University of CreteRecruitingSevere Eosinophilic Asthma w/wo CRSwNPGreece
-
University of PisaRecruitingHematopoietic Stem Cell Transplantation | Graft Versus Host Disease, AcuteItaly
-
University Hospital, LimogesRecruitingHepatitis C | Hepatitis C Virus Infection, Response to Therapy of | Addiction, Alcohol | Addiction Opiate | Transmission, Intravenous Drug AbuserFrance
-
Grupo Argentino de Tratamiento de la Leucemia AgudaNot yet recruitingChronic Lymphocytic Leukemia
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingMerkel Cell Carcinoma | Cutaneous Melanoma | Cutaneous Squamous Cell CarcinomaUnited States
-
Known Medicine, Inc.M.D. Anderson Cancer Center; Mayo Clinic; Duke Cancer InstituteRecruitingCancer | Effects of Chemotherapy | Predictive Cancer ModelUnited States
-
Jun Zhang, MD, PhDNilogen OncosystemsRecruitingNSCLC | Lung Cancer | NSCLC Stage IVUnited States
-
The University of QueenslandRecruitingKidney Transplant Infection | Kidney Transplant Failure and Rejection | BK ViremiaAustralia
-
Duke UniversityNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsRecruitingCommon Variable Immunodeficiency | X-linked Agammaglobulinemia | Primary Immune Deficiency | Primary Antibody Deficiencies | CVID | XLA | Secondary HypogammaglobulinemiaUnited States
-
Korea University Guro HospitalAjou University School of Medicine; Korean Center for Disease Control and Prevention and other collaboratorsRecruitingInflammation | Vaccine Adverse Reaction | Vaccine Immune Response | COVID-19 VaccinationKorea, Republic of
-
ANRS, Emerging Infectious DiseasesCIRBA, Abidjan, Ivory Coast; SEREFO, Bamako, Mali; BIOLIM/FSS/UL, Lomé, TogoNot yet recruiting
-
Institute of Tropical Medicine, BelgiumRecruitingImmune ResponseCongo, The Democratic Republic of the
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); The Arthritis Society, CanadaRecruitingJuvenile Idiopathic ArthritisCanada
-
Lei LiRecruitingRecurrent Cervical Carcinoma | Radiotherapy | Immunotherapy | Survival Outcomes | Immune Checkpoint Inhibitors | Objective Response Rate | Metastatic Cervical Carcinoma | Tislelizumab | Persistent Cervical Carcinoma | Anti-programmed Cell Death Receptor 1China
-
University of LiverpoolRecruitingSurgery | Preterm | Nutritional Deficiency | Immune System and Related DisordersUnited Kingdom
-
Yantai Yuhuangding HospitalRecruiting
-
Eastern Virginia Medical SchoolRecruitingLaryngeal Nerve Block | Chronic Neurogenic Cough | Laryngeal HypersensitivityUnited States
-
Yale UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Recruiting
-
Institut PasteurJanssen Biotech, Inc.Recruiting
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; FONCER contre...RecruitingRenal Cell Carcinoma | Renal Cancer | Renal Cancer MetastaticFrance
-
Institut CurieMerck Sharp & Dohme LLCRecruitingMetastatic Uveal MelanomaFrance
-
Dr. Frank BehrensBionorica SERecruiting
-
University of MichiganRegeneron PharmaceuticalsRecruiting
-
Novartis PharmaceuticalsRecruitingLupus NephritisFrance, Spain, Israel, Turkey, United States, Germany, India, Hungary, Malaysia, Portugal, Brazil, China, Puerto Rico, Hong Kong, Mexico, Singapore
-
Maastricht University Medical CenterMerck Sharp & Dohme LLC; Erasmus Medical Center; Medical Center Haaglanden; Albert... and other collaboratorsRecruitingImmune System Disorder | Preterm | Vaccination FailureNetherlands
-
Catholic University of the Sacred HeartNot yet recruitingThrombotic Thrombocytopenic Purpura, AcquiredItaly
-
Korea University Guro HospitalKorea University Anam Hospital; Ajou University School of Medicine; Korean Center... and other collaboratorsRecruitingCOVID-19 | Vaccine Adverse Reaction | Vaccine Immune ResponseKorea, Republic of
-
Fudan UniversityRecruitingDiffuse Large B-cell LymphomaChina
-
University Hospital, MontpellierRecruiting
-
University Hospital BirminghamNot yet recruiting
-
Medical University of SilesiaMaria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,...RecruitingNewly Diagnosed GlioblastomaPoland
-
Mayo ClinicRecruitingCandidiasis | Fungal InfectionUnited States
-
The Central Hospital of Lishui CityNot yet recruiting
-
Chulalongkorn UniversityBioNet-Asia; Chula Clinical Research Center (Chula CRC), Faculty of Medicine... and other collaboratorsRecruitingSafety of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | Tolerability of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | Immune Response of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | Safety of 50 ug of ChulaCov19-BNA159 mRNA Vaccine | Tolerability of 50 ug of ChulaCov19-BNA159 mRNA Vaccine | Immune Response... and other conditionsThailand
-
Leiden University Medical CenterRecruitingAutoimmune HepatitisNetherlands
-
Iowa State UniversityRecruitingImmunizationUnited States
-
Inmunotek S.L.Not yet recruiting
-
Boston Children's HospitalChildren's Hospital Colorado; Celiac Disease FoundationRecruitingGastrointestinal Diseases | Celiac Disease | Malabsorption Syndromes | Digestive System Disease | Gluten Sensitivity | Intestinal Disease | Celiac Disease in ChildrenUnited States